Coeptis Therapeutics, Inc. Operating Cash Flow
Coeptis Therapeutics, Inc. reported Operating Cash Flow of -$3.03 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-11-08
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-09-30 was -$1.03M.
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-06-30 was -$1.03M, a 4258.20% decline year-over-year.
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$961.73K.
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$208.88K.
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2021 was -$4.49M.
- Coeptis Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2020 was -$3.14M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 8 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 10 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.07M derived: sum of 2 quarters · filed 2022-11-08 | -$3.03M 10-Q · filed 2022-11-08 | -$3.24M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-06-30 | -$1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$2.00M 10-Q · filed 2022-08-02 | -$2.20M derived: sum of 3 quarters · filed 2022-08-02 | -$5.85M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2022-03-31 | -$961.73K 10-Q · filed 2022-05-12 | -$1.17M derived: sum of 2 quarters · filed 2022-05-12 | -$4.82M derived: sum of 3 quarters · filed 2022-11-08 | -$4.80M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-12-31 | -$208.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$3.86M derived: sum of 2 quarters · filed 2022-11-08 | -$3.83M derived: sum of 3 quarters · filed 2022-11-08 | -$4.49M 10-K · filed 2022-03-11 | ||||
| 2021-09-30 | -$3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$3.63M derived: sum of 2 quarters · filed 2022-11-08 | -$4.28M 10-Q · filed 2022-11-08 | -$4.87M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $24.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$630.41K 10-Q · filed 2022-08-02 | -$1.22M derived: sum of 3 quarters · filed 2022-08-02 | |||||
| 2021-03-31 | -$655.27K 10-Q · filed 2022-05-12 | -$1.24M derived: sum of 2 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | -$584.61K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$28.49K 10-KT · filed 2021-05-11 | -$3.14M 10-K · filed 2022-03-11 | |||||
| 2020-11-30 | -$3.35K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-01-11 | -$25.91K 10-Q · filed 2021-01-11 | ||||||
| 2020-09-30 | -$913.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$960.88K derived: sum of 2 quarters · filed 2021-11-15 | -$2.55M 10-Q · filed 2021-11-15 | |||||
| 2020-08-31 | -$22.55K 10-Q/A · filed 2020-11-23 | |||||||
| 2020-06-30 | -$47.15K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | -$1.64M 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$1.59M 10-Q/A · filed 2021-05-18 | |||||||
| 2019-12-31 | $0.00 10-KT · filed 2021-05-11 | |||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 | |||||||
| 2019-08-31 | -$99.00 10-Q/A · filed 2020-11-23 |